A phase I dose-finding study of everolimus in combination with capecitabine and oxaliplatin (XELOX) as the first-line chemotherapy for patients with advanced gastric cancer.
Inkeun Park
No relevant relationships to disclose
Min-Hee Ryu
No relevant relationships to disclose
Baek-Yeol Ryoo
No relevant relationships to disclose
Myoung Joo Kang
No relevant relationships to disclose
Changsuk Lee
No relevant relationships to disclose
Young Soo Park
No relevant relationships to disclose
Yoon-Koo Kang
Honoraria - Novartis
Research Funding - Novartis